In addition, patients with non-alcoholic fatty liver disease (NAFLD) exhibited a high level of SIRT4, which was accompanied by upregulation of the expression and activity of lipogenesis-related enzymes/proteins in liver [71]. Here, SIRT4 is linked to metabolic dysfunction-associated steatotic liver disease.